Analysis of antigenic heterogeneity within individual 3-methylcholanthrene-induced mouse sarcomas.

No abstract is available for this paper.

• Publication year

  1970

• Venue

  Journal of the National Cancer Institute

• Publication date

  1970-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/45.5.1039PMID 18605432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE RELATIONSHIP OF IMMUNOLOGY TO CARCINOGENESIS *

  1969cited by this paper
• Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens.

  1969cited by this paper
• 6-Phosphogluconate Dehydrogenase: Hemizygous Manifestation in a Patient with Leukemia

  1969cited by this paper
• The effect of thymectomy and of the dose of 3-methylcholanthrene on the induction and antigenic properties of sarcomas in C56Bl mice.

  1968cited by this paper
• Transplantation methods as a tool for detection of tumor-specific antigens.

  1965cited by this paper
• ANTIGENIC SPECIFICITY OF BENZO(A)PYRENE-INDUCED SARCOMAS.

  1964cited by this paper
• Immunity to methylcholanthrene-induced sarcomas.

  1957cited by this paper
• Neoplastic growth.

  1956cited by this paper
• Gradual transformation of solid into ascites tumors; evidence favoring the mutation-selection theory.

  1955cited by this paper
• Origin of the Resistance of Leukæmic Cells to Folic Acid Antagonists

  1952cited by this paper

• Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity

  2019cites this paper
• Tumor Antigens

  2019cites this paper
• EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

  2017cites this paper
• Trends and advances in tumor immunology and lung cancer immunotherapy

  2016cites this paper
• Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging

  2015cites this paper
• Evolution of the cancer stem cell model.

  2014cites this paper
• Imaging Breast Cancer Progression and Lymph Node Metastases in Murine Models Using MRI and Magnetic Nanoparticles

  2013cites this paper
• Mobilizing and evaluating anticancer T cells: pitfalls and solutions

  2013cites this paper
• MRI detection of nonproliferative tumor cells in lymph node metastases using iron oxide particles in a mouse model of breast cancer.

  2013cites this paper
• Characterization of Tumour-initiating Cells in Human Colorectal Cancer

  2012cites this paper
• Animal Models in Radiotracer Design

  2011cites this paper
• Translating Tumor Antigens into Cancer Vaccines

  2010cites this paper
• Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

  2009cites this paper
• Cancer may be caused by the Immune Reaction

  2008cites this paper
• The flip side of immune surveillance: immune dependency

  2008cites this paper
• The evolution of diversity within tumors and metastases

  2008cites this paper
• Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials1

  2007cites this paper
• Characterizationof High-and Low-MetastaticClones Derivedfrom a Methylcholanthrene-inducedMurineFibrosarcoma 1

  2006cites this paper
• Analyse quantitative in vivodes réctions immunitaires dirigées contre les antigénes associés a des tumeurs murines solides

  2006cites this paper
• MammaryTumorVirusDNAas a Marker for GenotypicVariance within Hormone-responsive GR Mouse Mammary Tumors

  2006cites this paper
• Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity

  2005cites this paper
• How to escape immune surveillance?

  2004cites this paper
• Intratumor immunologic heterogeneity

  2004cites this paper
• Natural resistance mechanisms may play a role in protection against chemical carcinogenesis

  2004cites this paper
• Tumor cell antigenicity, host immunity, and cancer metastasis

  2004cites this paper
• Tumor heterogeneity: biological implications and therapeutic consequences

  2004cites this paper
• The selective nature of metastasis

  2004cites this paper
• Phenotypic diversity in leukemia cell populations

  2004cites this paper
• Influence of implantation site on formation of metastases

  2004cites this paper
• Organ specific metastasis with special reference to avian systems

  2004cites this paper
• Experimental systems for analysis of the malignant phenotype

  2004influential citation
• Purified mouse mammary tumor and lymphoid cells in immune assays

  2004cites this paper
• Cancer vaccines.

  2001cites this paper
• Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.

  1996cites this paper
• Tumor markers as targets for selective diagnostic and therapeutic procedures.

  1996cites this paper
• TAG-72 expression and its role in the biological evaluation of human colorectal cancer.

  1996cites this paper
• The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma.

  1996cites this paper
• Stimulatory effects of immune reactions upon the growths of untransplanted tumors.

  1994cites this paper
• Myth of tumor immunology (review).

  1993cites this paper
• Selfish cells in altruistic cell society - a theoretical oncology.

  1993cites this paper
• Targeting antibodies to live tumor tissue in 3-D histoculture

  1992cites this paper
• The inhibition of tumor growth by tumor mass.

  1991cites this paper
• RadioimmunoguidedTM Surgery in Breast Cancer

  1991cites this paper
• Maintenance of expression of tumor antigens in three-dimensional in vitro human tumor gel-supported histoculture.

  1991cites this paper
• Freedom from wholism in multicellular organisms: a possible role of tumor suppressor genes.

  1991cites this paper
• In vitro and in vivo regulation of tumor antigen expression by human recombinant interferons.

  1991cites this paper
• F11C antigen: A membrane marker able to distinguish two regressive and progressive variants from a rat colon adenocarcinoma

  1990cites this paper
• Molecular oncogenetics of metastasis.

  1990cites this paper
• Growth of metastases of the mouse adenocarcinoma EO 771: an allometric relationship between growth of the primary tumors and their metastases

  1990cites this paper
• Reversible changes in tumor growth and metastatic behavior induced by immune pressure.

  1990cites this paper
• The flip side of tumor immunity.

  1989cites this paper
• Tumor-specific antigens as altered growth factor receptors.

  1989cites this paper
• Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.

  1989cites this paper
• Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines.

  1989cites this paper
• Therapeutic implications of tumor heterogeneity.

  1989cites this paper
• Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3.

  1989cites this paper
• Phenotypic Heterogeneity and Metastasis

  1989cites this paper
• A perspective of monoclonal antibodies: past, present, and future.

  1989cites this paper
• Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones.

  1988cites this paper
• Establishment of highly metastatic clones without tumorigenicity derived from Dunn osteosarcoma.

  1988cites this paper
• Proliferative potential of brain metastases

  1988cites this paper
• Experimental metastasis. Dissemination and growth of lymphoma cells in mice.

  1988cites this paper
• The biology of cancer metastasis and implications for therapy.

  1987cites this paper
• Phenotypic heterogeneity of a tumor-associated antigen in adenocarcinomas of the colon and their metastases as demonstrated by monoclonal antibody B72.3.

  1986cites this paper
• Biology and Biochemistry of Metastatic Cells

  1986cites this paper
• Antigenic heterogeneity of long-term cultured renal carcinoma cell line (KU-2) analyzed by tumor specific monoclonal antibodies.

  1986cites this paper
• Advances in Immunity and Cancer Therapy

  1986cites this paper
• Problems Posed for Cancer Treatment by Tumor Cell Heterogeneity

  1986cites this paper
• Characterization of spontaneous metastases from autochthonous 3-methylcholanthrene-induced tumors.

  1986cites this paper
• Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.

  1986cites this paper
• Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.

  1986cites this paper
• Implications of tumor progression on clinical oncology

  1985cites this paper
• Monoclonal antibodies reactive with breast tumor-associated antigens.

  1985cites this paper
• Antigenic heterogeneity of human anaplastic gliomas and glioma-derived cell lines defined by monoclonal antibodies.

  1985cites this paper
• Interaction between two cellular subpopulations of a rat colonic carcinoma when inoculated to the syngeneic host

  1985cites this paper
• Factors influencing differential growth of rat mammary tumor fragments and cells transplanted in gland-free and gland-containing mammary fat pads.

  1985cites this paper
• Heterogeneity in surface antigen of cell lines and clones from a murine carcinoma

  1985cites this paper
• Active specific immunotherapy as an adjunct to the treatment of metastatic solid tumors: present and future prospects.

  1985cites this paper
• Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins.

  1985cites this paper
• Lattice theory approach to metastatic disease patterns in autopsied human patients: Application to metastatic neuroblastoma

  1985cites this paper
• The effect of immunity on pulmonary metastasis of a methylcholanthrene‐induced fibrosarcoma and three of its clones

  1984cites this paper
• Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.

  1984cites this paper
• Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.

  1984cites this paper
• Immunomodulation of host resistance by tumor variants.

  1984cites this paper
• Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma.

  1984cites this paper
• Recent concepts of cancer metastasis and their implications for therapy.

  1984cites this paper
• Immunoperoxidase staining of early human melanoma colonies with monoclonal antibodies. A new method for in vitro antigenic-morphologic correlation.

  1984cites this paper
• The value of secretory component (SC) immunoreactivity in diagnosis and prognosis of colorectal carcinomas.

  1984cites this paper
• Practical considerations for the establishment of a screening procedure for the assessment of biological response modifiers.

  1984cites this paper
• 6 – Macrophage Activation by Lymphokines: Usefulness as Antimetastatic Agents

  1984cites this paper
• Tumor heterogeneity.

  1984cites this paper
• Tumor Cell Heterogeneity in Primary and Metastatic Colorectal Carcinoma

  1984cites this paper
• Successful immunotherapy in a murine metastasizing fibrosarcoma model

  1984cites this paper
• Antigenic Heterogeneity of Human Mammary Carcinoma Cells Defined by Monoclonal Antibodies

  1984cites this paper
• Specificity of tumour associated transplantation antigens (TATA) of different clones from the same tumour.

  1984cites this paper
• Disease-First: A New Paradigm for Environmental Health Science Research

  1984cites this paper
• Monoclonal antibodies to breast cancer‐associated antigens as potential reagents in the management of breast cancer

  1984cites this paper
• Cytokinetics of subpopulations in mixed polyploid tumors by television imaging. III. 3H-thymidine incorporation by ploidy subpopulations--control of 3H-absorption and emulsion efficiency in autoradiography.

  1984cites this paper
• Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.

  1983cites this paper
• Concomitant tumor immunity and the resistance to a second tumor challenge.

  1983cites this paper